Aerie Pharmaceuticals
AERI
#6501
Rank
โ‚น68.06 B
Marketcap
โ‚น1,377
Share price
0.00%
Change (1 day)
95.57%
Change (1 year)

Revenue for Aerie Pharmaceuticals (AERI)

Revenue in 2022 (TTM): โ‚น16.37 Billion

According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น19.32 Billion. In 2021 the company made a revenue of โ‚น14.44 Billion an increase over the revenue in the year 2020 that were of โ‚น6.08 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aerie Pharmaceuticals from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น16.37 B13.29%
2021 โ‚น14.44 B137.65%
2020 โ‚น6.08 B22%
2019 โ‚น4.98 B194.76%
2018 โ‚น1.69 B
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Insmed
INSM
โ‚น40.37 B 108.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น6.40 B-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.801 T 29,924.63%๐Ÿ‡บ๐Ÿ‡ธ USA